Everyone’s focus on Covid-19 and its implications for the economy and markets means other issues have slipped under the radar, writes tomstevenson63
Three months ago, my wife and I were enjoying a week driving round the Alentejo region of Portugal, eating in busy little restaurants and averting our gaze from what looked like a nasty situation developing in northern Italy.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China's COVID-19 vaccine 'safe' in world's first completed human trialA Chinese study of 108 volunteers found that none of them had serious side effects from a coronavirus vaccine created there. It's a good sign, but Dr Peter Hotez says it may not trigger blocking antibodies.
Read more »
China's COVID-19 vaccine 'safe' in world's first completed human trialA Chinese study of 108 volunteers found that none of them had serious side effects from a coronavirus vaccine created there. It's a good sign, but Dr Peter Hotez says it may not trigger blocking antibodies.
Read more »
Josephine Matseke Peter: Daughter's tribute to nurse who treated COVID-19 patientsBuhle Peter says her mum spent her career preserving human life, helping others and 'sharing that glow she had and spreading joy'.
Read more »
Volunteer reach out to Mexico City's homeless impacted by COVID-19Since late March, Mexico City nonprofit organization El Caracol has serviced 800 homeless persons and handed out 1,400 kits to prevent the outbreak of the coronavirus pandemic.
Read more »
Missouri hairstylist may have exposed 91 people to Covid-19, officials sayStylist worked at a salon on eight different days while experiencing symptoms after governor allowed businesses to reopen
Read more »
China's COVID-19 vaccine 'safe' in world's first completed human trialA Chinese study of 108 volunteers found that none of them had serious side effects from a coronavirus vaccine created there. It's a good sign, but Dr Peter Hotez says it may not trigger blocking antibodies.
Read more »